Tweet
In my case I forgot the -C for colorspace reads. Since bowtie won't run in this case, it will give the same error message. This behavior of tophat really needs to be corrected and the output of bowtie has to be shown on screen.
-
-
For anyone else who runs into this problem: Get the file logs/run.log from your tophat output directory. Search for the line that starts with bowtie and copy/paste it into a command line. Bowtie will fail and the error message tells you what the problem was.Comment
-
Here is a patch for tophat 1.2.0 that fixes this:
< if not os.path.isfile(unmapped_reads_fasta_name):
< sys.stderr.write("Error: Bowtie results not found, error message from bowtie was:\n")
< logData = open(logging_dir + tmp_fname + ".log").read()
< sys.stderr.write(logData)
< sys.exit(1)
<Comment
-
Thank you for your post. I fix the problem. I realised that I was using the whole genome itself instead the reads..
Comment
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment